Works matching IS 25785745 AND DT 2024 AND VI 6 AND IP 9


Results: 11
    1
    2
    3
    4
    5
    6

    Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study.

    Published in:
    ACR Open Rheumatology, 2024, v. 6, n. 9, p. 581, doi. 10.1002/acr2.11697
    By:
    • Habib, Rami;
    • Dayam, Roya M.;
    • Hitchon, Carol;
    • Chandran, Vinod;
    • Fortin, Paul R.;
    • Boire, Gilles;
    • Bowdish, Dawn M. E.;
    • Gingras, Anne‐Claude;
    • Flamand, Louis;
    • Larché, Maggie J.;
    • Colmegna, Ines;
    • Lukusa, Luck;
    • Lee, Jennifer L. F.;
    • Pereira, Daniel;
    • Bernstein, Charles N.;
    • Lalonde, Nadine;
    • Turnbull, Elizabeth;
    • Bernatsky, Sasha
    Publication type:
    Article
    7

    Phage Immunoprecipitation‐Sequencing Reveals CDHR5 Autoantibodies in Select Patients With Interstitial Lung Disease.

    Published in:
    ACR Open Rheumatology, 2024, v. 6, n. 9, p. 568, doi. 10.1002/acr2.11696
    By:
    • Upadhyay, Vaibhav;
    • Yoon, Young me;
    • Vazquez, Sara E.;
    • Velez, Tania E.;
    • Jones, Kirk D.;
    • Lee, Cathryn T.;
    • Law, Christopher S.;
    • Wolters, Paul J.;
    • Lee, Seoyeon;
    • Yang, Monica M.;
    • Farrand, Erica;
    • Noth, Imre;
    • Strek, Mary E.;
    • Anderson, Mark S.;
    • DeRisi, Joseph L.;
    • Sperling, Anne I.;
    • Shum, Anthony K.
    Publication type:
    Article
    8
    9
    10
    11

    Issue Information.

    Published in:
    ACR Open Rheumatology, 2024, v. 6, n. 9, p. 529, doi. 10.1002/acr2.11565
    Publication type:
    Article